Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12176
PUT
Televisa
TV
$1.45B
| $31.1K | ﹤0.01% |
+10,700
| New | +$29.2K |
|
|
LPRO
12177
CALL
DELISTED
Open Lending Corp
LPRO
| $31K | ﹤0.01% |
20,000
-7,400
| -27% | -$13.1K |
|
12178
Gogoro
GGR
$56.2M
| $30.9K | ﹤0.01% |
11,264
+2,208
| +24% | +$8.9K |
|
12179
CALL
Protalix BioTherapeutics
PLX
$191M
| $30.6K | ﹤0.01% |
+17,000
| New | +$34.8K |
|
12180
EpicQuest Education Group
EEIQ
$3.57M
| $30.5K | ﹤0.01% |
8,771
+924
| +12% | +$5.34K |
|
12181
Taoping
TAOP
$7.83M
| $30.5K | ﹤0.01% |
+21,811
| New | +$50.5K |
|
|
YXT
12182
YXT.COM Group Holding Ltd
YXT
| $30.3K | ﹤0.01% |
3,839
-1,688
| -31% | -$15K |
|
|
PTIX
12183
DELISTED
Performance Technologies
PTIX
| $30.3K | ﹤0.01% |
+23,311
| New | +$52.6K |
|
12184
PUT
Heron Therapeutics
HRTX
$96.8M
| $30.3K | ﹤0.01% |
23,300
-36,300
| -61% | -$44.8K |
|
12185
PUT
Coherus Oncology
CHRS
$228M
| $29.8K | ﹤0.01% |
21,000
-98,700
| -82% | -$144K |
|
12186
CALL
Good Times Restaurants
GTIM
$14.8M
| $29.5K | ﹤0.01% |
24,400
+10,000
| +69% | +$14K |
|
12187
PUT
OraSure Technologies
OSUR
$287M
| $29.5K | ﹤0.01% |
+12,200
| New | +$32.1K |
|
12188
CALL
Hyperfine
HYPR
$101M
| $29.5K | ﹤0.01% |
30,100
+3,700
| +14% | +$4.46K |
|
12189
Cardio Diagnostics
CDIO
$5.15M
| $29.4K | ﹤0.01% |
10,858
-8,662
| -44% | -$31.5K |
|
|
TMDE
12190
TMD Energy Limited
TMDE
$16.9M
| $29.4K | ﹤0.01% |
+69,216
| New | +$49.6K |
|
12191
CALL
CarParts.com
PRTS
$44.9M
| $29.1K | ﹤0.01% |
+5,820
| New | +$32.6K |
|
12192
Snail Inc
SNAL
$34.7M
| $28.9K | ﹤0.01% |
+6,506
| New | +$32K |
|
|
WYHG
12193
Wing Yip Food Holdings
WYHG
$43.9M
| $28.9K | ﹤0.01% |
13,123
+4,164
| +46% | +$15.8K |
|
12194
Harvard Bioscience
HBIO
$28.5M
| $28.8K | ﹤0.01% |
+4,299
| New | +$25.5K |
|
12195
Galmed Pharmaceuticals
GLMD
$4.75M
| $28.7K | ﹤0.01% |
38,177
-12,315
| -24% | -$14.4K |
|
12196
Swvl Holdings
SWVL
$13.5M
| $28.6K | ﹤0.01% |
+15,057
| New | +$41.8K |
|
12197
CALL
Codexis
CDXS
$154M
| $28.5K | ﹤0.01% |
17,500
+1,300
| +8% | +$2.65K |
|
12198
CALL
NanoViricides
NNVC
$38.8M
| $28.5K | ﹤0.01% |
25,200
-12,100
| -32% | -$17K |
|
12199
Integrated Media Technology
IMTE
$1.65M
| $28.5K | ﹤0.01% |
+48,802
| New | +$41.9K |
|
12200
CALL
Playboy Inc
PLBY
$141M
| $28.4K | ﹤0.01% |
15,100
-23,300
| -61% | -$38.1K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.